journal article·2014-07-09Open access

NMR as Evaluation Strategy for Cellular Uptake of Nanoparticles

Tomas Orlando, Alessandro Paolini, Francesco Pineider, Emanuela Clementi, Francesca Pasi, Yannick Guari, Joulia Larionova, Luciano Sacchi, Rosanna Nano, Maurizio Corti, Alessandro Lascialfari

Nano Letters· Volume 14· Issue 7

Abstract

Advanced nanostructured materials, such as gold nanoparticles, magnetic nanoparticles, and multifunctional materials, are nowadays used in many state-of-the-art biomedical application. However, although the engineering in this field is very advanced, there remain some fundamental problems involving the interaction mechanisms between nanostructures and cells or tissues. Here we show the potential of (1)H NMR in the investigation of the uptake of two different kinds of nanostructures, that is, maghemite and gold nanoparticles, and of a chemotherapy drug (Temozolomide) in glioblastoma tumor cells. The proposed experimental protocol provides a new way to investigate the general problem of cellular uptake for a variety of biocompatible nanostructures and drugs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Advanced NMR Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physics and INSTM Unit, University of Pavia, Pavia, Italy

Department of Medical Physics, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy

Department of Biology and Biotecnology “Lazzaro Spallanzani”, University of Pavia, Pavia, Italy

CNR-ISTM, Padova, Italy

Department of Chemistry and INSTM Unit, University of Florence, Sesto Fiorentino (FI), Italy

Institute Charles Gerhardt Montpellier, CNRS, Chimie Moléculaire et Organisation du Solide, Université Montpellier II, Montpellier, France

Department of Physics and INSTM Unit, Università degli Studi di Milano, Milan, Italy

References (41)

Show source-provided references
1. Pankhurst Q. · J. Phys. D: Appl. Phys. · 2009 · 42 · 22400110.1088/0022-3727/42/22/224001 ↗
2. Davis M. E. · Nat. Rev. Drug Discovery · 2008 · 7 · 77110.1038/nrd2614 ↗
3. Roca a G. · J. Phys. D: Appl. Phys. · 2009 · 42 · 22400210.1088/0022-3727/42/22/224002 ↗
4. Flacke S. · Circulation · 2001 · 104 · 128010.1161/hc3601.094303 ↗
5. Massoud T. F. · Genes Dev. · 2003 · 17 · 54510.1101/gad.1047403 ↗
6. Ghosh D. · Nat. Nanotechnol. · 2012 · 7 · 67710.1038/nnano.2012.146 ↗
7. Jordan A. · J. Magn. Magn. Mater. · 2001 · 225 · 11810.1016/S0304-8853(00)01239-7 ↗
8. Scherer F. · Gene Ther. · 2002 · 9 · 10210.1038/sj.gt.3301624 ↗
9. Berry C. C. · J. Phys. D: Appl. Phys. · 2009 · 42 · 22400310.1088/0022-3727/42/22/224003 ↗
10. Janib S. M. · Adv. Drug Delivery Rev. · 2010 · 62 · 105210.1016/j.addr.2010.08.004 ↗
11. Lu C.-W. · Nano Lett. · 2007 · 7 · 14910.1021/nl0624263 ↗
12. Dreaden E. C. · Chem. Soc. Rev. · 2012 · 41 · 274010.1039/C1CS15237H ↗
13. Dreaden E. C. · Bioconjugate Chem. · 2009 · 20 · 224710.1021/bc9002212 ↗
14. Alvarez Y. D. · Nano Lett. · 2013 · 13 · 615610.1021/nl403490e ↗
15. Arosio P. · J. Mater. Chem. B · 2013 · 1 · 531710.1039/c3tb00429e ↗
16. Jiang W. · Nat. Nanotechnol. · 2008 · 3 · 14510.1038/nnano.2008.30 ↗
17. Haick H. · J. Phys. D: Appl. Phys. · 2007 · 40 · 717310.1088/0022-3727/40/23/S01 ↗
18. Chithrani B. D. · Nano Lett. · 2006 · 6 · 66210.1021/nl052396o ↗
19. Albanese A. · Annu. Rev. Biomed. Eng. · 2012 · 14 · 110.1146/annurev-bioeng-071811-150124 ↗
20. Lévy M. · Contrast Media Mol. Imaging · 2012 · 7 · 37310.1002/cmmi.504 ↗
21. Lee H. · Nat. Med. · 2008 · 14 · 86910.1038/nm.1711 ↗
22. Semmling M. · Small · 2008 · 4 · 176310.1002/smll.200800596 ↗
23. Zhang F. · Small · 2011 · 7 · 311310.1002/smll.201100608 ↗
24. Adamson C. · Expert Opin. Invest. Drugs · 2009 · 18 · 106110.1517/13543780903052764 ↗
25. Nano R. · Anticancer Res. · 2012 · 32 · 2755
26. Lartigue L. · J. Am. Chem. Soc. · 2011 · 133 · 1045910.1021/ja111448t ↗
27. Cho E. C. · Nat. Nanotechnol. · 2011 · 6 · 38510.1038/nnano.2011.58 ↗
28. Whittall K. P. · Magn. Reson. Med. · 1997 · 37 · 3410.1002/mrm.1910370107 ↗
29. Lascialfari A. · Magn. Reson. Med. · 2005 · 53 · 132610.1002/mrm.20481 ↗
30. Roch A. · J. Chem. Phys. · 1999 · 110 · 540310.1063/1.478435 ↗
31. DeLean A. · Am. J. Physiol. · 1978 · 235 · E9710.1152/ajpcell.1978.235.3.C97 ↗
32. Arrang J. · Nature · 1987 · 327 · 11710.1038/327117a0 ↗
33. Kenakin T. · Trends Pharmacol. Sci. · 1995 · 16 · 18810.1016/S0165-6147(00)89020-3 ↗
34. Chambers J. · Nature · 1999 · 400 · 26110.1038/22313 ↗
35. Nangia-Makker P. · Trends Mol. Med. · 2002 · 8 · 18710.1016/S1471-4914(02)02295-5 ↗
36. Kimling J. · J. Phys. Chem. B · 2006 · 110 · 1570010.1021/jp061667w ↗
37. Spiegl-Kreinecker S. · Br. J. Cancer · 2007 · 96 · 96010.1038/sj.bjc.6603652 ↗
38. DeAngelis L. M. · Semin. Onc. · 2003 · 30 · 1510.1053/j.seminoncol.2003.11.037 ↗
39. Robinson C. G. · Br. J. Cancer · 2010 · 103 · 49810.1038/sj.bjc.6605792 ↗
40. Kanzawa T. · Cell Death Differ. · 2004 · 11 · 44810.1038/sj.cdd.4401359 ↗
41. Kerr J. · Br. J. Cancer · 1972 · 26 · 23910.1038/bjc.1972.33 ↗